Total Payments
$1,125
2023 Payments
$16.59
Companies
15
Transactions
31
Medicare Patients
11,096
Medicare Billing
$593,937
Payment Breakdown by Category
Food & Beverage$1,125 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,125 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $182.66 | 11 | $0 (2022) |
| Novo Nordisk Inc | $140.33 | 2 | $0 (2018) |
| Dexcom, Inc. | $125.61 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $125.00 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.15 | 1 | $0 (2017) |
| Abbott Laboratories | $105.30 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $100.22 | 1 | $0 (2017) |
| PFIZER INC. | $66.53 | 4 | $0 (2018) |
| Shire North American Group Inc | $57.66 | 3 | $0 (2018) |
| Corcept Therapeutics | $23.75 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16.59 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($16.59) |
| 2022 | $65.55 | 4 | Lilly USA, LLC ($51.60) |
| 2019 | $125.61 | 1 | Dexcom, Inc. ($125.61) |
| 2018 | $233.59 | 7 | Novo Nordisk Inc ($125.00) |
| 2017 | $683.53 | 18 | GlaxoSmithKline, LLC. ($125.00) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Gastroenterology | ||||||
| 11/15/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/27/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 08/25/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 10/23/2019 | Dexcom, Inc. | DEXCOM CGM (Device) | Food and Beverage | In-kind items and services | $125.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/14/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 07/11/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/13/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Diabetes | ||||||
| 05/30/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 05/02/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/11/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/09/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/13/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/07/2017 | Lilly USA, LLC | TRADJENTA (Drug), TRULICITY, BASAGLAR | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 11/08/2017 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Endocrinology | ||||||
| 11/06/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $100.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/05/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.33 | General |
| 09/01/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
| 07/12/2017 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $11.99 | General |
| Category: Cardiovascular | ||||||
| 05/31/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/24/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 04/28/2017 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes | ||||||
| 04/25/2017 | Abbott Laboratories | FreeStyle Libre Pro (Device), FreeStyle Libre Pro, FreeStyle Libre Pro | Food and Beverage | In-kind items and services | $105.30 | General |
| Category: Diabetes Care | ||||||
| 03/29/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $123.15 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 961 | 1,368 | $112,150 | $53,351 |
| 2022 | 65 | 3,405 | 4,683 | $329,440 | $159,753 |
| 2021 | 72 | 3,886 | 4,889 | $404,065 | $186,004 |
| 2020 | 76 | 2,844 | 4,431 | $434,142 | $194,829 |
Total Patients
11,096
Total Services
15,371
Medicare Billing
$593,937
Procedure Codes
243
All Medicare Procedures & Services
243 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 220 | $31,400 | $17,776 | 56.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 35 | 73 | $5,910 | $4,453 | 75.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $7,000 | $4,171 | 59.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 37 | $5,255 | $3,741 | 71.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 35 | 43 | $7,150 | $3,175 | 44.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 17 | 17 | $9,900 | $3,135 | 31.7% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 19 | 20 | $6,400 | $2,835 | 44.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 32 | $2,650 | $1,590 | 60.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 31 | 52 | $2,160 | $1,574 | 72.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 45 | 46 | $4,600 | $1,334 | 29.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 15 | 15 | $3,100 | $1,199 | 38.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 78 | $2,750 | $1,009 | 36.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 53 | 54 | $1,890 | $888.84 | 47.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 60 | $4,380 | $750.72 | 17.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 48 | 49 | $1,960 | $724.22 | 37.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 50 | 52 | $1,300 | $682.24 | 52.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 52 | 53 | $2,120 | $504.56 | 23.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 22 | 22 | $1,130 | $474.54 | 42.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 55 | $1,075 | $462.00 | 43.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 31 | 32 | $1,280 | $427.52 | 33.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 53 | 54 | $1,890 | $410.94 | 21.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 38 | 39 | $780.00 | $403.65 | 51.7% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 12 | 12 | $600.00 | $361.44 | 60.2% |
| 82746 | Folic acid level, serum | Office | 2023 | 22 | 22 | $880.00 | $317.02 | 36.0% |
| 83550 | Iron binding capacity | Office | 2023 | 32 | 33 | $990.00 | $282.81 | 28.6% |
About Dr. Leonard Levitz, MD
Dr. Leonard Levitz, MD is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346277738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Levitz, MD has received a total of $1,125 in payments from pharmaceutical and medical device companies, with $16.59 received in 2023. These payments were reported across 31 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,125).
As a Medicare-enrolled provider, Levitz has provided services to 11,096 Medicare beneficiaries, totaling 15,371 services with total Medicare billing of $593,937. Data is available for 4 years (2020–2023), covering 243 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Brooklyn, NY
- Active Since 06/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346277738
Products in Payments
- JARDIANCE (Drug) $138.55
- DEXCOM CGM (Device) $125.61
- BREO ELLIPTA (Drug) $125.00
- Tresiba (Drug) $125.00
- FreeStyle Libre Pro (Device) $105.30
- ENTRESTO (Drug) $100.22
- TRULICITY (Drug) $85.65
- GATTEX (Drug) $57.66
- MOUNJARO (Drug) $36.20
- LYRICA (Drug) $34.72
- Korlym (Drug) $23.75
- Vascepa (Drug) $18.06
- XIFAXAN (Drug) $16.59
- CHANTIX (Drug) $16.25
- TRADJENTA (Drug) $15.71
- FLECTOR PATCH (Drug) $15.56
- BASAGLAR (Drug) $15.09
- HUMALOG (Drug) $14.61
- XARELTO (Drug) $14.07
- LINZESS (Drug) $13.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Internal Medicine $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733